Ocean Biomedical CEO Elizabeth Ng (L) and Aesther CEO Suren Ajjarapu
September 20, 2022 07:41 AM EDT
Financing
Deals

One SPAC's jour­ney to find a part­ner, and its race against the clock, shows tough­ness of bear mar­ket

Max Gelman

Senior Editor

The once-boom­ing SPAC mar­ket has been a slog this year, with merg­ers seem­ing­ly falling apart left and right. One blank check com­pa­ny’s new proxy state­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

A service from the Financial Times